Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myriad Genetics (MYGN) Amortizatization of Intangibles (2019 - 2025)

Historic Amortizatization of Intangibles for Myriad Genetics (MYGN) over the last 7 years, with Q3 2025 value amounting to $1.0 million.

  • Myriad Genetics' Amortizatization of Intangibles fell 5652.17% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.4 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $9.5 million for FY2024, which is 1592.92% down from last year.
  • Myriad Genetics' Amortizatization of Intangibles amounted to $1.0 million in Q3 2025, which was down 5652.17% from $2.8 million recorded in Q2 2025.
  • Over the past 5 years, Myriad Genetics' Amortizatization of Intangibles peaked at $3.5 million during Q1 2021, and registered a low of $1.0 million during Q3 2025.
  • Its 5-year average for Amortizatization of Intangibles is $2.7 million, with a median of $2.8 million in 2023.
  • Examining YoY changes over the last 5 years, Myriad Genetics' Amortizatization of Intangibles showed a top increase of 3333.33% in 2025 and a maximum decrease of 5652.17% in 2025.
  • Quarter analysis of 5 years shows Myriad Genetics' Amortizatization of Intangibles stood at $3.0 million in 2021, then rose by 3.33% to $3.1 million in 2022, then dropped by 12.9% to $2.7 million in 2023, then increased by 3.7% to $2.8 million in 2024, then plummeted by 64.29% to $1.0 million in 2025.
  • Its Amortizatization of Intangibles was $1.0 million in Q3 2025, compared to $2.8 million in Q2 2025 and $2.8 million in Q1 2025.